Cargando…
Chromogranin A Tubulopathy: Differing Histopathologic Patterns of Acute Tubular Injury in the Setting of Neuroendocrine Neoplasms
INTRODUCTION: Neoplasms of neuroendocrine derivation or differentiation may express specific peptides, some of which are capable of producing clinical symptomatology and others used as biomarkers: one such peptide being chromogranin A (CGA). Herein, we describe histopathologic changes present in kid...
Autores principales: | Sekulic, Miroslav, Waikar, Sushrut, Motwani, Shveta S., Weins, Astrid, Rennke, Helmut G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698283/ https://www.ncbi.nlm.nih.gov/pubmed/31440699 http://dx.doi.org/10.1016/j.ekir.2019.04.025 |
Ejemplares similares
-
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality—The Boston Kidney Biopsy Cohort Study
por: Srivastava, Anand, et al.
Publicado: (2021) -
Low Efficacy of Chromogranin A Elimination by Therapeutic Plasma Exchange for Treatment of Chromogranin A Tubulopathy
por: Hakroush, Samy, et al.
Publicado: (2021) -
Clinical Usefulness of Plasma Chromogranin A in Pancreatic Neuroendocrine Neoplasm
por: Paik, Woo Hyun, et al.
Publicado: (2013) -
Osmotic Tubulopathy in a Patient With COVID-19 Treated With Remdesivir
por: Wongboonsin, Janewit, et al.
Publicado: (2021) -
Crystalline light chain proximal tubulopathy and podocytopathy: a case report
por: Patel, Ankit B., et al.
Publicado: (2019)